These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 3519177

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Guanfacine and other centrally acting drugs in antihypertensive therapy; pharmacological and clinical aspects.
    Saameli K, Jerie P, Scholtysik G.
    Clin Exp Hypertens A; 1982; 4(1-2):209-19. PubMed ID: 6280899
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA, Thoolen MJ, Timmermans PB.
    Hypertension; 1984; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M, Weiss Y, Georges D.
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension.
    Finnerty FA, Brogden RN.
    Drugs; 1985 Jul; 30(1):22-31. PubMed ID: 3896742
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
    Distler A, Kirch W, Lüth B.
    Br J Clin Pharmacol; 1980 Jul; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M, Overlack A, Stumpe KO.
    Br J Clin Pharmacol; 1980 Jul; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [Abstract] [Full Text] [Related]

  • 18. Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat.
    Thoolen MJ, Hendriks JC, Timmermans PB, van Zwieten PA.
    J Cardiovasc Pharmacol; 1983 Jul; 5(2):224-8. PubMed ID: 6188894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Guanfacine hydrochloride: a centrally acting antihypertensive agent.
    Cornish LA.
    Clin Pharm; 1988 Mar; 7(3):187-97. PubMed ID: 3281788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.